Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions - PubMed (original) (raw)
Comparative Study
Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions
Gail M Verge et al. Eur J Neurosci. 2004 Sep.
Abstract
Fractalkine is a unique chemokine reported to be constitutively expressed by neurons. Its only receptor, CX3CR1, is expressed by microglia. Little is known about the expression of fractalkine and CX3CR1 in spinal cord. Given that peripheral nerve inflammation and/or injury gives rise to neuropathic pain, and neuropathic pain may be partially mediated by spinal cord glial activation and consequent glial proinflammatory cytokine release, there must be a signal released by affected neurons that triggers the activation of glia. We sought to determine whether there is anatomical evidence implicating spinal fractalkine as such a neuron-to-glia signal. We mapped the regional and cellular localization of fractalkine and CX3CR1 in the rat spinal cord and dorsal root ganglion, under basal conditions and following induction of neuropathic pain, employing both an inflammatory (sciatic inflammatory neuropathy; SIN) as well as a traumatic (chronic constriction injury; CCI) model. Fractalkine immunoreactivity and mRNA were observed in neurons, but not glia, in the rat spinal cord and dorsal root ganglia, and levels did not change following either CCI or SIN. By contrast, CX3CR1 was expressed by microglia in the basal state, and the microglial cellular concentration was up-regulated in a regionally specific manner in response to neuropathy. CX3CR1-expressing cells were identified as microglia by their cellular morphology and positive OX-42 and CD4 immunostaining. The cellular distribution of fractalkine and CX3CR1 in the spinal circuit associated with nociceptive transmission supports a potential role in the mechanisms that contribute to the exaggerated pain state in these models of neuropathy.
Similar articles
- Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.
Milligan ED, Zapata V, Chacur M, Schoeniger D, Biedenkapp J, O'Connor KA, Verge GM, Chapman G, Green P, Foster AC, Naeve GS, Maier SF, Watkins LR. Milligan ED, et al. Eur J Neurosci. 2004 Nov;20(9):2294-302. doi: 10.1111/j.1460-9568.2004.03709.x. Eur J Neurosci. 2004. PMID: 15525271 - Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain.
Lindia JA, McGowan E, Jochnowitz N, Abbadie C. Lindia JA, et al. J Pain. 2005 Jul;6(7):434-8. doi: 10.1016/j.jpain.2005.02.001. J Pain. 2005. PMID: 15993821 - An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine.
Milligan E, Zapata V, Schoeniger D, Chacur M, Green P, Poole S, Martin D, Maier SF, Watkins LR. Milligan E, et al. Eur J Neurosci. 2005 Dec;22(11):2775-82. doi: 10.1111/j.1460-9568.2005.04470.x. Eur J Neurosci. 2005. PMID: 16324111 - Fractalkine in vascular biology: from basic research to clinical disease.
Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshie O, Imai T. Umehara H, et al. Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):34-40. doi: 10.1161/01.ATV.0000095360.62479.1F. Epub 2003 Sep 11. Arterioscler Thromb Vasc Biol. 2004. PMID: 12969992 Review. - Role of the immune system in neuropathic pain.
Malcangio M. Malcangio M. Scand J Pain. 2019 Dec 18;20(1):33-37. doi: 10.1515/sjpain-2019-0138. Scand J Pain. 2019. PMID: 31730538 Review.
Cited by
- NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice.
Fotio Y, Mabou Tagne A, Squire E, Lee HL, Phillips CM, Chang K, Ahmed F, Greenberg AS, Villalta SA, Scarfone VM, Spadoni G, Mor M, Piomelli D. Fotio Y, et al. Nat Commun. 2024 Feb 24;15(1):1705. doi: 10.1038/s41467-024-46139-5. Nat Commun. 2024. PMID: 38402219 Free PMC article. - Macrophages and microglia in inflammation and neuroinflammation underlying different pain states.
Chen O, Luo X, Ji RR. Chen O, et al. Med Rev (2021). 2023 Nov 1;3(5):381-407. doi: 10.1515/mr-2023-0034. eCollection 2023 Oct. Med Rev (2021). 2023. PMID: 38283253 Free PMC article. - Neuropathic pain; what we know and what we should do about it.
Smith PA. Smith PA. Front Pain Res (Lausanne). 2023 Sep 22;4:1220034. doi: 10.3389/fpain.2023.1220034. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 37810432 Free PMC article. Review. - Transcriptome profiling in rumen, reticulum, omasum, and abomasum tissues during the developmental transition of pre-ruminant to the ruminant in yaks.
Liu Y, Min Q, Tang J, Yang L, Meng X, Peng T, Jiang M. Liu Y, et al. Front Vet Sci. 2023 Sep 22;10:1204706. doi: 10.3389/fvets.2023.1204706. eCollection 2023. Front Vet Sci. 2023. PMID: 37808112 Free PMC article. - Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases.
Lana D, Magni G, Landucci E, Wenk GL, Pellegrini-Giampietro DE, Giovannini MG. Lana D, et al. Int J Mol Sci. 2023 Sep 5;24(18):13668. doi: 10.3390/ijms241813668. Int J Mol Sci. 2023. PMID: 37761971 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous